If you are looking to invest in TearLab Corporation’s (NASDAQ:TEAR), or currently own the stock, then you need to understand its beta in order to understand how it can affect the risk of your ...

ESCONDIDO, Calif., May 11, 2020 /PRNewswire/ -- TearLab Corporation (OTCQB: TEAR), a leader in Ocular Surface Diagnostics, today announced it has entered into a definitive agreement pursuant to which ...

ESCONDIDO, Calif., May 07, 2020 (GLOBE NEWSWIRE) -- In light of recent market rumors, TearLab Corporation (TEAR) (“TearLab”) today confirmed that TearLab is engaged in advanced discussions regarding a ...

SOUTHLAKE, Texas--(BUSINESS WIRE)--TearLab® Corporation, the global leader in ophthalmic point-of-care diagnostics, announced today that it will be expanding its position in corneal health under the ...

SOUTHLAKE, Texas, Dec. 9, 2021 /PRNewswire/ -- TearLab Corporation, a global ophthalmic diagnostics company marketing point-of-care laboratory testing, today announced that Adam Szaronos has been ...

ESCONDIDO, Calif., April 22, 2020 (GLOBE NEWSWIRE) -- TearLab Corporation (OTCQB: TEAR) (“TearLab” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has accepted the ...

TearLab (TEU +0.00%) is looking to widen its capital base by more than $32 million in an underwritten public offering of its common stock. The company is floating 2.6 million shares at a price of ...

SAN DIEGO, April 28, 2011 (GLOBE NEWSWIRE) -- TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) expects to announce its 2011 financial results for the first quarter before the market opens on Wednesday, May ...

TearLab (NAS: TEAR) reported earnings on May 13. Here are the numbers you need to know. The 10-second takeaway For the quarter ended March 31 (Q1), TearLab beat expectations on revenues and exceeded ...